败血症后的慢性肌肉衰弱可以通过对线粒体的药理保护来预防
Meagan S Kingren1,2,3, Alexander R Keeble2,4,5, Alyson M Galvan-Lara3
1Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA.
Molecular medicine (Cambridge, Mass.)
|November 20, 2024
概括
线粒体异常会在败血症后导致慢性骨肌肉衰弱. 在败血症期间保护线粒体可以预防这种弱点,为败血症幸存者提供潜在的治疗策略.
科学领域:
- 生物医学研究的研究.
- 败血症的病理生理学
- 骨肌肉生物学 骨肌肉生物学
背景情况:
- 败血症是住院和长期并发症的主要原因,特别是幸存者的慢性骨肌肉衰弱.
- 在败血症后的骨肌肉中观察到线粒体异常,但它们在软弱中的因果作用尚不清楚.
- 这项研究调查了线粒体功能障碍和败血症后慢性肌肉衰弱之间的联系.
研究的目的:
- 为了确定线粒体异常是否有因果关系,导致败血症后慢性骨肌肉衰弱.
- 探索线粒体作为潜在的治疗点,以预防败血症后的肌肉衰弱.
主要方法:
- 通过使用 cecal slurry 注射建立了严重败血症的小鼠模型.
- 用转基因小鼠评估线粒体功能和肌肉强度,这些小鼠过度表达了超氧化物失调酶 (MnSOD) 和用SS-31进行药理治疗.
- 在体内和体外技术,组织学,生物化学和mRNA测序被用来分析肌肉变化.
主要成果:
- 败血症后的骨肌弱逐渐与累积的线粒体异常和改变的线粒体基因表达一起发展.
- 过度表达MnSOD的小鼠显示出对线粒体损伤和肌肉软弱的保护.
- 在败血症期间使用SS-31进行线粒体保护,可以防止随后肌肉衰弱的发展.
结论:
- 线粒体异常的积累是发生败血症后慢性骨肌肉衰弱的主要驱动因素.
- 在急性败血症期间针对线粒体的药理学向是缓解长期肌肉衰弱的有希望的临床策略.
相关概念视频
Muscle Recovery and Fatigue
2.0K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
2.0K
The Electron Transport Chain
16.1K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
16.1K
Skeletal Muscle Relaxants: Adverse Effects
335
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
335
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Electron Transport Chain: Complex I and II
11.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.7K
Myasthenia Gravis: Diagnostic Tests
653
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
653


